152 related articles for article (PubMed ID: 4860604)
1. Some effects of purified heterologous antihuman lymphocyte serum in man.
Monaco AP; Wood ML; Russell PS
Transplantation; 1967 Jul; 5(4):Suppl:1106-14. PubMed ID: 4860604
[No Abstract] [Full Text] [Related]
2. The relationship of lymphopenia production and lymphocyte agglutinating and cytotoxic antibody titers to the immunosuppressive potency of heterologous antilymphocyte plasma.
Jeejeebhoy HF
Transplantation; 1967 Jul; 5(4):Suppl:1121-6. PubMed ID: 4963509
[No Abstract] [Full Text] [Related]
3. Heterologous antilymphocyte sera and some of their effects.
Russell PS; Monaco AP
Transplantation; 1967 Jul; 5(4):Suppl:1086-99. PubMed ID: 4860603
[No Abstract] [Full Text] [Related]
4. Antilymphocyte serum: summary and further observations.
Woodruff MF
Transplantation; 1967 Jul; 5(4):Suppl:1127-33. PubMed ID: 4860606
[No Abstract] [Full Text] [Related]
5. Immunosuppressive potency and in-vitro activity of antilymphocyte globulin.
Greaves MF; Tursi A; Playfair JH; Torrigiani G; Zamir R; Roitt IM
Lancet; 1969 Jan; 1(7585):68-72. PubMed ID: 4180096
[No Abstract] [Full Text] [Related]
6. Cytotoxic antibodies after skin allotransplantation in rabbits.
Matej H
Arch Immunol Ther Exp (Warsz); 1970; 18(1):29-41. PubMed ID: 4908940
[No Abstract] [Full Text] [Related]
7. Anti-lymphocyte serum.
James K
Clin Chim Acta; 1968 Sep; 22(1):101-13. PubMed ID: 4973561
[No Abstract] [Full Text] [Related]
8. In vivo antibody production by spleen cells after incubation in vitro with heterologous antilymphocyte plasma.
Jeejeebhoy HF; Rabbat AG
Nature; 1968 Dec; 220(5174):1350-2. PubMed ID: 4882918
[No Abstract] [Full Text] [Related]
9. Heterologous antilymphocyte serum: differential effect on antigen-sensitive and antibody-producing cells.
Möller G; Zukoski CF
Surgery; 1968 Jul; 64(1):39-47. PubMed ID: 5658739
[No Abstract] [Full Text] [Related]
10. Cell mediated immune reactions "in vitro". Reactivity of lymphocytes from animals sensitized to chicken erythrocytes, tuberculin or transplantation antigens.
Chapuis B; Brunner KT
Int Arch Allergy Appl Immunol; 1971; 40(3):321-39. PubMed ID: 5313314
[No Abstract] [Full Text] [Related]
11. Antilymphocyte serum or antithymus serum.
Nagaya H
Arch Intern Med; 1970 Mar; 125(3):499-502. PubMed ID: 4906901
[No Abstract] [Full Text] [Related]
12. Variations in rabbit antimouse lymphocyte sera caused by lymphocytes of differing origins in the immunizing inocula.
Miller J; Tanner D; Cohn R
Transplantation; 1970 Apr; 9(4):352-65. PubMed ID: 4927383
[No Abstract] [Full Text] [Related]
13. Solubilization of lymphocyte and thymocyte antigens by a reversible chemical modification.
Eshhar Z; Gafni M; Givol D; Sela M
Eur J Immunol; 1971 Nov; 1(5):323-9. PubMed ID: 4945634
[No Abstract] [Full Text] [Related]
14. [TRANSPLANTATION IMMUNITY. ON THE MECHANISM OF ANTIGENS IN HOMOGRAFTS].
FUJII G
Sogo Igaku; 1964 Mar; 21():215-20. PubMed ID: 14137779
[No Abstract] [Full Text] [Related]
15. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
Monaco AP; Franco DJ
Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
[No Abstract] [Full Text] [Related]
16. [Biologic fundamentals and advances in kidney transplantation. IV. Immunosuppression with antilymphocytic serum and specific tolerances].
Lawson RK; Kirchheim D
Urologe; 1967; 6(6):359-67. PubMed ID: 4873352
[No Abstract] [Full Text] [Related]
17. Studies on the mode of action of heterologous anti-lymphocyte plasma. II. The effect of anti-lymphocyte plasma on lymphocyte counts.
Jeejeebhoy HF; Vela-Martinez JM
Transplantation; 1968 Mar; 6(2):149-59. PubMed ID: 4871384
[No Abstract] [Full Text] [Related]
18. In vitro expression of homograft reactions.
Lawrence HS; al-Askari S
Transplant Proc; 1969 Mar; 1(1):400-2. PubMed ID: 4944249
[No Abstract] [Full Text] [Related]
19. Prolongation of canine renal allograft survival with antilymphoid antisera.
Shanfield I; Ladaga LG; Wren SF; Blennerhassett JB; MacLean LD
Surg Gynecol Obstet; 1968 Jul; 127(1):29-40. PubMed ID: 4872534
[No Abstract] [Full Text] [Related]
20. Use of minimal doses of lymphoid cells for production of heterologous antilymphocyte serum.
Gozzo JJ; Wood ML; Monaco AP
Transplant Proc; 1971 Mar; 3(1):779-83. PubMed ID: 4937972
[No Abstract] [Full Text] [Related]
[Next] [New Search]
